Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma

Shlomit Kfir-Erenfeld, Nathalie Asherie*, Eyal Lebel, Vladimir Vainstein, Miri Assayag, Tatyana Dubnikov Sharon, Sigal Grisariu, Batia Avni, Shlomo Elias, Rivka Alexander-Shani, Nomi Bessig, Alaa Shehadeh, Aseel Ishtay, Veronica Zelmanovich, Eran Zimran, Marjorie Pick, Ilan Roziner, Ron S. Kenett, Yael Cohen, Irit AviviCyrille J. Cohen, Moshe E. Gatt, Polina Stepensky

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology